Document Detail


Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease.
MedLine Citation:
PMID:  23325065     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The efficacy and safety of liposomal amphotericin B (L-AMB) in the treatment of invasive fungal infections (IFIs) were retrospectively evaluated for patients with connective tissue diseases (CTDs) during treatment with immunosuppressive therapy. Subjects were 13 patients with CTDs complicated by IFI, on the basis of clinical symptoms, imaging findings, and microbiological and histological examinations. All patients were treated with L-AMB. Efficacy and safety were evaluated before and after administration of L-AMB. Underlying diseases were systemic lupus erythematosus for 4 patients, rheumatoid arthritis for 3, microscopic polyangiitis for 2, adult-onset Still disease for 1, dermatomyositis for 1, and mixed connective tissue disease for 1. Eight patients were resistant to other antifungal drugs. Prednisolone was given to 11 patients and the median dose was 10 mg/day. Immunosuppressants were used for 8 patients. The median duration of administration of L-AMB was 8.5 days (range 4-38 days). In proven and probable diagnosis patients (n = 5), the treatment was effective for 3 patients and ineffective for 2 (efficacy rate 60 %). Serum 1,3-β-D-glucan antigenemia (BG) levels decreased after treatment in the 2 patients who were positive for BG. Serum Aspergillus galactomannan antigen levels decreased in 3 of 4 patients with Aspergillus infection. No patient died of IFI. Regarding potential adverse reactions, there were no significant changes in serum creatinine and potassium levels. L-AMB is effective and well-tolerated for treatment of IFI in patients with CTDs.
Authors:
Takuya Kotani; Tohru Takeuchi; Shigeki Makino; Kenichiro Hata; Shuzo Yoshida; Koji Nagai; Daisuke Wakura; Kentaro Isoda; Toshiaki Hanafusa
Related Documents :
24236015 - Sputum inflammatory profile before and after specific inhalation challenge in individua...
24752865 - Fish analysis of washing urine from the upper urinary tract for the detection of urothe...
24001965 - Transient ischemic attack: omen and opportunity.
24697265 - Pediatric post-traumatic headaches and peripheral nerve blocks of the scalp: a case ser...
15933925 - The clinical value of taking routine biopsies from the incisura angularis during gastro...
2357135 - The widened mediastinum. diagnostic and therapeutic priorities.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy     Volume:  -     ISSN:  1437-7780     ISO Abbreviation:  J. Infect. Chemother.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9608375     Medline TA:  J Infect Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of factors affecting variations in influenza A/H1N1 history in university students, Japan...
Next Document:  Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthoo...